Why invest in DanubeNeuro?
"An investment in knowledge pays the best interest"
-Benjamin Franklin
The longevity and neurodegeneration industry generated $25.1 billion in 2020 and is expected to reach $44.2 billion by 2030, witnessing a CAGR of 6.1% from 2021 to 2030
We keep up to date with emerging trends and rigorously evaluate the developmental state of academic fields to ensure investment in disruptive technologies and assets with high potential returns
Our cross-functional team of experienced entrepreneurs, business developers, and researchers evaluates each academic project for scientific rigor and quality, development feasibility, and commercialization potential to de-risk your investment
Our established network of investors shares our vision for improving the healthspan of the aged population and those suffering from neurodegenerative diseases
Breakthrough projects are managed by experienced professionals